The anti-snoring treatment market is expected to grow at a CAGR of 10.8% during the forecast period of 2025 to 2033, driven by the increasing prevalence of snoring and the growing awareness of its health implications. Snoring is a common condition caused by the obstruction of airflow during sleep, resulting in loud and disruptive noises.
The companion animal vaccines market is expected to grow at a CAGR of 5.5% during the forecast period of 2025 to 2033. The companion animal vaccines market is a rapidly growing sector within the veterinary industry. Companion animal vaccines are specifically designed to protect pets, including dogs, cats, and horses, from various infectious diseases. These vaccines play a crucial role in preventing the spread of diseases, ensuring the health and well-being of companion animals.
CRISPR and Cas genes have become one of the most promising tools in the field of genetic engineering, revolutionizing the way we approach gene editing and genetic manipulation. The CRISPR/Cas system is a naturally occurring mechanism in bacteria that allows them to defend themselves against invading viruses. This system can be adapted to target and modify specific genes, making it a powerful tool in research and medicine.
The titanium electrode market has witnessed significant growth in recent years, driven by various factors such as increasing demand from key end-use industries, growing investments in research and development, and rising environmental concerns. The market revenue for titanium electrodes is expected to continue its upward trajectory during the forecast period of 2025 to 2033.
The global lithium bromide absorption machine market has been experiencing steady revenue growth. The market is expected to grow at a CAGR of around 4.5% during the forecast period of 2025 to 2033. The global lithium bromide absorption machine market has been witnessing significant growth in recent years, driven by the increasing demand for sustainable cooling solutions in various end-use industries.
The creep and rupture testing machine market is witnessing steady growth due to the increasing demand for material testing across various industries. Creep and rupture testing machines are used to determine the mechanical properties and performance of materials under high-temperature and long-duration conditions. These machines find application in industries such as aerospace, automotive, energy, and materials science, among others.
The SLS (Sodium Lauryl Sulfate) and LABSA (Linear Alkyl Benzene Sulfonic Acid) markets are important segments of the global surfactant industry. The SLS and LABSA market is expected to grow at a CAGR of 4.5% during the forecast period of 2025 to 2033. Surfactants are widely used in various applications, such as personal care products, detergents, industrial and institutional cleaning, agriculture, and oilfield chemicals, among others.
The periodontal treatment market refers to the global market for products and services used in the treatment of periodontal disease, a common dental condition that affects the soft tissues and bone supporting the teeth.The global periodontal treatment market size is expected to grow at a CAGR of around 6.5% during the forecast period of 2025 to 2033. Periodontal disease is a common dental condition caused by bacterial infections that damage the soft tissues and bone supporting the teeth.
The global alkaline solid waste market is expected to grow at a CAGR of 4% during the forecast period of 2025 to 2033. Significant demand exists to maximize waste reuse and recycling in order to reduce the environmental impact of waste treatment and disposal. Many sectors, including iron/steel, cement/concrete, pulp/paper, and chemicals, produce alkaline solid waste on a global scale.
The global market for transport protein assays kits is anticipated to grow at a CAGR of 12.3% from 2025 to 2033. To move molecules across the plasma membrane, transport proteins perform both active and passive transport functions. This is expected to boost the growth of the market for transport protein assay kits over the forecast period.
The drugs by therapeutic area market covers pharmaceutical products classified according to the diseases and medical conditions they are designed to treat. Major therapeutic areas include oncology, cardiovascular diseases, diabetes and other metabolic disorders, neurological conditions, infectious diseases, respiratory disorders, immunology, gastrointestinal diseases, dermatology, ophthalmology, women’s health and rare diseases. The category includes prescription drugs, generic medicines, biologics, biosimilars, vaccines and advanced therapies.
The wider global pharmaceutical market provides an appropriate benchmark for evaluating growth across therapeutic drug categories. One current industry estimate projects the pharmaceutical market to increase from approximately USD 1.88 trillion in 2026 to USD 3.22 trillion by 2035, representing a compound annual growth rate of 6.15%. North America held the largest regional share in 2025, while Asia-Pacific is expected to demonstrate notable growth through 2035.
Market growth is being supported by the increasing prevalence of chronic and age-related diseases. Rising cases of cancer, diabetes, cardiovascular disorders, arthritis, respiratory diseases and neurological conditions are creating sustained demand for effective treatments. Population ageing, lifestyle changes, urbanization and improved access to diagnosis are further expanding the number of patients receiving long-term therapy.
Oncology remains an important area for pharmaceutical research and commercial investment. Development activity includes targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, cell therapies and personalized cancer treatments. Diabetes and obesity drugs are also recording strong demand, supported by the wider use of GLP-1 and other metabolic treatments. Neurology research is expanding across Alzheimer’s disease, Parkinson’s disease, epilepsy and mental health conditions.
Biologic drugs and biosimilars represent major market trends. Biologics are increasingly used to treat cancer, autoimmune diseases and rare disorders, while biosimilars can improve access after reference-product patent expiry. Pharmaceutical companies are also developing gene therapies, RNA-based medicines and other advanced treatments for conditions with limited existing options.
Precision medicine is influencing drug development across multiple therapeutic areas. Biomarkers, genomic testing and companion diagnostics help identify patients who are more likely to respond to specific medicines. Artificial intelligence is also being used for target identification, clinical-trial planning and analysis of real-world treatment data.
Market expansion may be restrained by high research costs, lengthy clinical development, regulatory uncertainty and drug-pricing pressure. Patent expirations can reduce revenue for branded products, while safety concerns or unsuccessful clinical trials may delay commercial launches. Access and reimbursement remain major challenges for expensive biologics and advanced therapies.
Acute Market Reports provides therapeutic-area drug research covering product classes, disease indications, routes of administration, distribution channels, company pipelines, competitive conditions and regional opportunities. These reports help pharmaceutical companies, investors, healthcare providers and distributors evaluate treatment demand and growth prospects through 2035.